The aggressiveness of ultramutated cancers can vary. While some ultramutated cancers may exhibit rapid growth and resistance to conventional therapies, others may respond well to targeted treatments like immunotherapy. The specific characteristics of the cancer, including its location, stage, and genetic profile, play a crucial role in determining its behavior.
